Regenerative Medical Technology Group Inc.: cashflow_financing
| Value | {"amount": 436900, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-09-30 |
| Status | current |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2dd44920-1bd7-4157-97c7-59dc8926bc5c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-011358Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/cashflow-financing/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2dd44920-1bd7-4157-97c7-59dc8926bc5c
History
- no predecessors — first report